Author Details

KANESTRI, V. G

Issue	Section	Title	File
No 3 (2012)	Articles	THE NOVEL HIV NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR RILPIVIRINE: A REVIEW OF INTERNATIONAL CLINICAL TRIALS
No 1 (2013)	Articles	USE OF THE FUSION INHIBITOR ENFUVIRTIDE IN ANTIRETROVIRAL THERAPY REGIMENS FOR HIV-INFECTED PATIENTS
No 2 (2013)	Articles	THE HEPATITIS C VIRUS PROTEASE INHIBITOR TELAPREVIR IN THERAPY REGIMENS FOR CHRONIC HEPATITIS C IN PATIENTS WITH HIV INFECTION
No 6 (2014)	Articles	DUAL ANTIRETROVIRAL THERAPY WITH LOPINAVIR AND RITONAVIR
No 1 (2015)	Articles	A fixed-dose combination of abacavir/lamivudine as a nucleoside basis for first-line antiretroviral therapy regimens
No 2 (2015)	Articles	EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY REGIMENS CONTAINING ETRAVIRINE FOR HIV-INFECTED PATIENTS
No 6 (2015)	Articles	HIV drug resistance: Dolutegravir is a second-generation HIV integrase inhibitor
No 2 (2016)	Articles	Use of non-boosted atazanavir in clinical practice
No 2 (2011)	Articles	THE HIV NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS ABACAVIR AND LAMIVUDINE IN FIRST-LINE ANTIRETROVIRAL THERAPY REGIMENS